Document:

Exhibit
10.7

 

FORWARD
SHARE PURCHASE AGREEMENT 

 

This
Forward Share Purchase Agreement (this “Agreement”) is entered into as of February [__], 2022, by and among (i) Edoc
Acquisition Corp Inc., a Cayman Islands exempted company (“EDOC”), (ii) [Investor Name], and (iii) [Investor
Name] (“[__]” and together with [__], each individually an “Investor” and collectively, the “Investors”).
Each of EDOC, [__] and [__] is individually referred to herein as a “Party” and collectively as the “Parties”.

 

Recitals

 

WHEREAS,
EDOC is a special purpose acquisition company, also known as a blank check company, formed for the purpose of effecting a merger, capital
stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses;

 

WHEREAS,
EDOC has entered into an Agreement and Plan of Merger, dated as of February [__], 2022 (the “Business Combination Agreement”),
by and among EDOC and Calidi Biotherapeutics, Inc., a Nevada corporation ( “Calidi”), among others, which agreement provides
for, among other things, the acquisition of Calidi by EDOC (the “Business Combination”), and EDOC intends to file
a proxy statement/prospectus with the U.S. Securities and Exchange Commission (the “Commission”) that will seek, among
other things, shareholder approval of the Business Combination at a special meeting of shareholders (the “Business Combination
Meeting”); and

 

WHEREAS,
the Parties wish to enter into this Agreement, pursuant to which the post-combination company (the “Company”) shall
purchase from the Investors, and the Investors may sell and transfer to the Company, in each case, subject to the conditions set forth
herein, certain EDOC Class A ordinary shares, par value $0.0001 per share, held by the Investors (the “Shares”) on
the terms set forth herein.

 

NOW,
THEREFORE, in consideration of the premises, representations, warranties and the mutual covenants contained in this Agreement, and for
other good and valuable consideration, the receipt, sufficiency and adequacy of which are hereby acknowledged, the Parties agree as follows:

 

Agreement

 

 1. Sale of Shares; Shares Purchase and Sale; Closing. 

 

(a) Forward
Share Purchase. Subject to the conditions set forth in Section 4, on the three (3) month anniversary of the date of the closing
of the Business Combination (the “Business Combination Closing Date”), the Investors may elect to sell and transfer
to the Company, and the Company shall purchase from the Investors, up to that number of Shares (including any Additional Shares) that
are then held by the Investors, and have been continuously held by the Investors since the Business Combination Closing Date, but not
to exceed [__] Shares (including any Additional Shares) in the aggregate unless otherwise agreed in writing by all Parties, at a price
per Share equal to $10.42 per Share (the “Shares Purchase Price”). Each Investor shall, notify the Company and the
Escrow Agent in writing no later than three (3) Business Days (as defined below) prior to the three (3) month anniversary of the Business
Combination Closing Date whether or not such Investor is exercising such Investor’s right to sell any of the Shares (including
any Additional Shares) held by such Investor to the Company pursuant to this Agreement (each, a “Shares Sale Notice”).
Notwithstanding anything herein to the contrary, if the closing sale price  of the Shares on the third (3rd) business
day prior to the three (3) month anniversary of the Business Combination is less than $10.42 per Share, the Investors’ right to
sell shall be deemed automatically exercised, without the need to deliver the Shares Sales Notice, as to all Shares held by the Investors.
Except as set forth in the preceding  sentence, any Investor that fails to timely deliver a Shares Sales Notice in accordance with
the immediately preceding sentence shall be deemed to have forfeited its right to sell any Shares (including any Additional Shares) to
the Company pursuant to this Agreement.

 

     

     

    

 

(b) Shares
Closing. If a Shares Sale Notice is timely delivered by any Investor to the Company and Escrow Agent, the closing of the sale of
the Shares contemplated in each such timely delivered Share Sales Notice (the “Shares Closing”) shall occur no later
than the three (3) month anniversary of the Business Combination Closing Date (the “Shares Closing Date”). On the
Shares Closing Date, each selling Investor shall deliver, or cause to be delivered, the Shares (including any Additional Shares) subject
to the applicable Shares Sale Notice free and clear of all liens and encumbrances to Escrow Agent and, in exchange therefor, the Escrow
Agent shall deliver to each such selling Investor(s) an amount equal to (i) the Shares Purchase Price multiplied by (ii) the number
of Shares being sold by such selling Investor (with respect to any particular selling Investor, the “Investor Shares Purchase
Price”), which shall be paid by wire transfer of immediately available funds from the Escrow Account. The Escrow Agent shall,
(i) without delay, release from the Escrow Account to each selling Investor on the Shares Closing Date, for such selling Investor’s
use without restriction, an amount equal to such Investor’s Investor Shares Purchase Price, and (ii) promptly deliver such sold
Shares to the Company.

 

2. Representations
and Warranties of the Investors. Each Investor represents and warrants to EDOC and Calidi, severally and not jointly, as of the date
hereof:

 

(a) Organization
and Power. Such Investor is duly organized, validly existing, and in good standing under the laws of the jurisdiction of its formation
and has all requisite power and authority to carry on its business as presently conducted and as proposed to be conducted.

 

(b) Authorization.
Such Investor has full power and authority to enter into this Agreement. This Agreement, when executed and delivered by such Investor
will constitute the valid and legally binding obligation of such Investor enforceable against it in accordance with its terms, except
(i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and any other laws of general
application affecting enforcement of creditors’ rights generally, or (ii) as limited by laws relating to the availability of specific
performance, injunctive relief or other equitable remedies ((i) and (ii) collectively, the “Enforceability Exceptions”).

 

(c) Governmental
Consents and Filings. No consent, approval, order or authorization of, or registration, qualification, designation, declaration or
filing with, any federal, state or local governmental authority is required on the part of such Investor in connection with the consummation
of the transactions contemplated by this Agreement (collectively, the “Transactions”) other than disclosure reports
regarding such transactions that such Investor is required to file in accordance with the terms of the Exchange Act (as defined below).

 

(d) Compliance
with Other Instruments. The execution, delivery and performance by such Investor of this Agreement and the consummation by such Investor
and the other Investors of the Transactions will not result in any violation or default (i) of any provisions of its organizational documents,
(ii) of any instrument, judgment, order, writ or decree to which it is a party or by which it is bound, (iii) under any note, indenture
or mortgage to which it is a party or by which it is bound, (iv) under any lease, agreement, contract or purchase order to which it is
a party or by which it is bound, or (v) of any provision of federal or state statute, rule or regulation applicable to it, in each case
(other than clause (i)), which would have a material adverse effect on such Investor or any of the other Investors or its or their ability
to consummate the Transactions.

 

    2

     

    

 

(e) Shareholdings;
Share Purchase by Investors. As of the date of this Agreement, the Investors collectively hold [●] Shares, with each Investor’s
holdings of Shares set forth on Appendix A hereto.

 

(f) Disclosure
of Information. Such Investor has had an opportunity to discuss EDOC’s and Calidi’s business, management and financial
affairs, and the terms and conditions of this Agreement, as well as the terms of the Business Combination, with EDOC’s management.

 

(g) No
Other Representations and Warranties; Non-Reliance. Except for the specific representations and warranties contained in this Section
2 and in any certificate or written agreement delivered pursuant hereto, neither any Investor nor any person acting on behalf of
such Investor nor any of such Investor’s affiliates (collectively, the “Investor Parties”) has made, makes or
shall be deemed to make any other express or implied representation or warranty with respect to such Investor or the other Investors,
and the Investor Parties disclaim any such representation or warranty. Except for the specific representations and warranties expressly
made by EDOC in Section 3 of this Agreement, in any certificate or written agreement delivered pursuant hereto and in any public
filings, the Investor Parties specifically disclaim that they are relying upon any other representations or warranties that may have
been made by the EDOC Parties (as defined below).

 

3. Representations
and Warranties of EDOC. EDOC represents and warrants to each Investor as follows:

 

(a) Organization
and Corporate Power. EDOC is a corporation duly incorporated, validly existing and in good standing as a corporation under the laws
of the Cayman Islands and has all requisite corporate power and authority to carry on its business as presently conducted and as proposed
to be conducted. EDOC has no subsidiaries other than the merger subsidiary referenced in the recitals hereto that was formed for the
purpose of effecting the Business Combination.

 

(b) Authorization.
All corporate action required to be taken by EDOC’s Board of Directors in order to authorize EDOC to enter into this Agreement
has been taken. This Agreement, when executed and delivered by EDOC, shall constitute the valid and legally binding obligation of EDOC,
enforceable against EDOC in accordance with its term, subject to the effect of the Enforceability Exceptions.

 

(c) Disclosure.
EDOC has not disclosed to either Investor material non-public information with respect to EDOC or the Business Combination, other than
any such information that shall be publicly disclosed by EDOC either by the issuance of a press release or the filing with the Commission
a Current Report on Form 8-K, in each case, by 9:30 a.m., Eastern Time on the first Business Day immediately following the date that
the Parties enter into this Agreement. Such public disclosure shall disclose the name of the Investors as having entered into the Agreement.

 

(d) Governmental
Consents and Filings. No consent, approval, order or authorization of, or registration, qualification, designation, declaration or
filing with, any federal, state or local governmental authority is required on the part of EDOC in connection with the consummation of
the Transactions, other than disclosure reports regarding such transactions EDOC is required to file in accordance with the terms of
the Exchange Act.

 

    3

     

    

 

(e) Compliance
with Other Instruments. The execution, delivery and performance by EDOC of this Agreement and the consummation by EDOC of the Transactions
will not result in any violation or default (i) of any provisions of its organizational documents, (ii) of any instrument, judgment,
order, writ or decree to which it is a party or by which it is bound, (iii) under any note, indenture or mortgage to which it is a party
or by which it is bound, (iv) under any lease, agreement, contract or purchase order to which it is a party or by which it is bound,
or (v) of any provision of federal or state statute, rule or regulation applicable to it, in each case (other than clause (i)), which
would have a material adverse effect on EDOC or its ability to consummate the Transactions.

 

(f) Adequacy
of Financing. The Company will have available to it sufficient funds to satisfy its obligations under this Agreement.

 

(g) SEC
Filings. To the knowledge of EDOC, none of EDOC’s reports and other filings with the Commission, as of their respective dates,
contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make
the statements therein, in light of the circumstances under which they were made, not misleading.

 

(h) No
Other Representations and Warranties; Non-Reliance. Except for the specific representations and warranties contained in this Section
3 and in any certificate or written agreement delivered pursuant hereto or in any public filings, neither EDOC or any person on behalf
of EDOC nor any of EDOC’s affiliates (collectively, the “EDOC Parties”) has made, makes or EDOC be deemed to
make any other express or implied representation or warranty with respect to EDOC, Calidi, the Transactions or the Business Combination,
and the EDOC Parties disclaim any such representation or warranty. Except for the specific representations and warranties expressly made
by the Investors in Section 2 of this Agreement and in any certificate or agreement delivered pursuant hereto, the EDOC Parties
specifically disclaim that they are relying upon any other representations or warranties that may have been made by the Investor Parties.

 

(i) Best
Efforts. EDOC will use reasonable best efforts to execute the Escrow Agreement with Continental Stock Transfer & Trust Company.

 

4. Additional
Agreements. 

 

(a) Net
Long Position. During the term of this Agreement, Investor agrees to maintain a net long position of the EDOC and/or the Company’s
securities.

 

		(i)	If,
                                            on the day that is three (3) trading days prior to EDOC’s special meeting of shareholders
                                            (the “Extension Meeting”) to approve, among other things, an extension
                                            (the “Extension”) of the date by which EDOC has to consummate an initial
                                            business combination from February 12, 2022 to August 12, 2022, EDOC’s Class A ordinary
                                            shares are trading at or below $10.27 and the Investors own, in the aggregate, fewer than
                                            [__] Shares, the Investors shall purchase Shares at trust value, in the first instance in
                                            the form of Shares tendered for redemption from the Escrow Agent (as defined herein) (the
                                            “Extension Redeemed Shares”), and if such Extension Redeemed Shares are
                                            not sufficient to allow the Investors to own, in the aggregate, at least [__]Shares, then
                                            the Investors shall thereafter purchase Shares, at trust value, in the open market, up to
                                            a number of Shares such that the Investors hold, in the aggregate, [__] Shares as of the
                                            time of the Extension Meeting if the stock is trading at or below trust value.

 

    4

     

    

 

		(ii)	During
                                            the period commencing on one (1) trading day following the Extension Meeting date until three
                                            (3) trading days prior to the Business Combination Meeting, the Investors shall have the
                                            right, but not the obligation, to sell any or all of the Shares subject to Sections 1,
                                            4(a)(i) and 4(b) in the open market if the sale price exceeds $10.27 per Share prior
                                            to payment of any commissions due by the Investor for such sale. The foregoing restriction
                                            does not apply to any Shares held by the Investors not subject to Sections 1, 4(a)(i)
                                            and 4(b).

 

		(iii)	If,
                                            on the day that is three (3) trading days prior to the Business Combination Meeting, the
                                            Investors hold fewer than [__] Shares, the Investors shall purchase Shares at trust value,
                                            in the first instance in the form of Shares tendered for redemption from the Escrow Agent
                                            (as defined herein) (the “Business Combination Redeemed Shares”), and
                                            if such Business Combination Redeemed Shares are not sufficient to allow the Investor to
                                            own at least [__]Shares, then the Investor shall thereafter purchase Shares, at trust value,
                                            in the open market, up to a number of Shares such that the Investors hold, in the aggregate,
                                            [__]Shares as of the time of the Business Combination Meeting if the stock is trading at
                                            or below trust value.

 

Notwithstanding
the foregoing, at any time from July 12, 2022 until four (4) trading days prior to the Business Combination Meeting, EDOC, in its sole
discretion, may reduce the number of Total Backstop Shares that shall be purchased by the Investors and the Additional Investors pursuant
to this Agreement and the Additional Investor Agreements. In such event, any reduction will be made and applied to the Investors and
the Additional Investors on a pro rata basis, and any Shares that the Investor shall purchase pursuant to this Section 4 shall be reduced
proportionately.

 

 (b) No Redemptions; No Tenders. Each Investor further agrees not to, (i) request redemption of any of the Shares (including any Additional Shares) subject to Sections 1, 4(a)(i), 4(a)(iii) and 4(b)in conjunction with EDOC’s shareholders’ approval of either the Extension or the Business Combination, or (ii) tender the Shares (including any Additional Shares) to EDOC in response to any redemption or tender offer that EDOC may commence for its Class A ordinary shares, par value $0.0001 per share. Notwithstanding the foregoing, in the event EDOC reduces the number of Shares subject to Section 4, the Investor may redeem a number of Shares equivalent to the number of Shares reduced pursuant to Section 4. The foregoing restriction does not apply to any Shares held by the Investors not subject to Sections 1, 4(a)(i), 4(a)(iii) and 4(b).

 

(c) Option
to Purchase Additional Shares and Certain Derivatives. EDOC hereby acknowledges that nothing in this Agreement shall prohibit the
Investors from purchasing from third parties prior to the Business Combination Closing Date additional Class A ordinary shares of EDOC,
including shares that have previously been tendered by third parties for redemption at their original redemption value in conjunction
with EDOC’s shareholders’ approval of the Business Combination, to the extent such third parties unwind such tenders for
redemption (the “Additional Shares”), or any warrants, convertible notes or options (including puts or calls) of EDOC;
provided, the aggregate number of Shares and Additional Shares owned by the Investors and subject to Sections 1, 4(a)(i),
4(a)(iii) and 4(b) shall not exceed [__] ordinary shares of EDOC, unless otherwise agreed in writing by all Parties. For the
avoidance of doubt, all Additional Shares shall be deemed Shares for all purposes hereunder and shall be purchased by the Company in
accordance with Section 1.

 

    5

     

    

 

(d) Open
Market Sale. Notwithstanding anything to the contrary herein, the Parties agree that the Investors shall, commencing on the Business
Combination Closing Date, have the right, but not the obligation, to sell any or all of the Shares (including any Additional Shares)
in the open market if the sale price exceeds $10.27 per Share prior to payment of any commissions due by the Investor for such sale.
The Investor shall give written notice to the Company and the Escrow Agent of any sale of the Shares (including any Additional Shares)
pursuant to this Section 4(d) within three (3) Business Days following the date of such sale (the “Open Market Sale Notice”)
if, as a result of such sales, the Investors hold less than an aggregate of the [__] Shares subject to Sections 1, 4(a) and 4(b), and
the Open Market Sale Notice shall include the date of the sale, the number of Shares sold, and confirmation that the sale price per Share
was greater than $10.27 per Share prior to the payment of any commissions due by the Investor for the sale. If the Investor sells any
of the [__] Shares (including any Additional Shares) subject to Sections 1, 4(a)(i), 4(a)(iii) and 4(b)in the open market after
the Business Combination Closing Date and prior to the one (1) month anniversary of the Business Combination Closing Date at a sales
price per Share that is greater than $10.27 (such sale, the “Early Sale” and such shares, the “Early Sale
Shares”), then, within five (5) Business Days of the Company’s and the Escrow Agent’s receipt of such Open Market
Sale Notice, the Escrow Agent shall release from the Escrow Account (x) to each selling Investor an amount equal to $0.05 per Early
Sale Share sold by the Investor (the “Early Sale Premium”) and (y) to the Company an amount equal to $10.37 per
Early Sale Share sold in such Early Sale.

 

(e) Escrow.

 

(i) Simultaneously
with the closing of the Business Combination, EDOC shall deposit, for good and valuable consideration, the receipt, sufficiency and adequacy
of which EDOC hereby acknowledges, into an escrow account (the “Escrow Account”) with Continental Stock Transfer &
Trust Company (the “Escrow Agent”), subject to the terms of a written escrow agreement (the “Escrow Agreement”)
substantially in the form attached as Exhibit A hereto and to be entered into on or prior to the Business Combination Closing
Date, an amount equal to the lesser of (x) $[__] and (y) $10.42 multiplied by the number of Shares and Additional Shares
held by the Investors as of the closing of the Business Combination, including after application of any ratable reduction as provided
for in Section 4(a) (the “Escrowed Funds”). The Escrow Agreement shall irrevocably cause the Escrow Agent to
release from the Escrow Account the aggregate Shares Purchase Price in accordance with Section 1. The payments to be made by the
Escrow Agent to the Investors in accordance with Section 1 or to the Investors and the Company in accordance with Section 4(d),
if applicable, will be made solely with the Escrowed Funds.

 

(ii) Upon
receipt by the Escrow Agent and Company of written notice that any Investor has sold Shares subject to Sections 1, 4(b) and 4(c)
above $10.27 (including any Additional Shares) as provided in Section 4(d), the Escrow Agent may release to the Company for the
Company’s use without restriction an aggregate amount equal to the number of Shares (including any Additional Shares) sold multiplied
by $10.42; provided that if an Investor sold any Shares (including any Additional Shares) before the one (1) month anniversary
of the Business Combination Closing Date, within five (5) Business Days of the Company’s and the Escrow Agent’s receipt of
the applicable notice from the Investor, the Escrow Agent shall release from the Escrow Account (a) for the selling Investor’s
use without restriction an amount equal to the number of Shares (including any Additional Shares) sold multiplied by $0.05 and
(b) for the Company’s use without restriction an amount equal to the number of Shares (including any Additional Shares) sold multiplied
by $10.37.

 

    6

     

    

 

(iii) In
the event that any Investor elects not to sell to the Company any of the [__] Shares (including any Additional Shares) subject to Sections
1, 4(a)(i), 4(a)(iii) and 4(b) held by such Investor by either (A) an Investor delivering a written notice to the Company on behalf
of itself stating such Investor’s intention not to sell any Shares (or any Additional Shares) to the Company, or (B) such Investor
failing to timely deliver a Shares Sale Notice to the Company pursuant to Section 1(a) for all of its Shares, the Company may
issue instructions to the Escrow Agent promptly upon the three (3) month anniversary of the Business Combination Closing Date to release
from the Escrow Account to the Company for the Company’s use without restriction an amount equal to (x) $10.42 multiplied
by (y) the number of Shares subject to Sections 1, 4(a)(i), 4(a)(iii) and 4(b) held by such Investor.

 

(f) Notification.
Edoc and/or the Company shall promptly notify the Investors of the occurrence of any event that would make any of the representations
and warranties of EDOC set forth in Section 3 untrue or incorrect at any time between the date of this Agreement and the
Shares Closing Date, except where the failure of a representation and warranty to be true and correct would not have a material adverse
effect on EDOC’s or the Company’s ability to consummate the Transactions.

 

(g) Most
Favored Nation. Concurrently with, or shortly after, the execution of this Agreement, EDOC may enter into separate agreements with
other investors (the “Additional Investors”) for the purchase and sale of EDOC ordinary shares imposing restrictions
on dispositions of EDOC ordinary shares by the Additional Investors similar to those herein ((i) and (ii) collectively, the “Additional
Investor Agreements”). EDOC has not and will not provide the Additional Investors material terms in the Additional Investor
Agreements that are more favorable to such Additional Investors than the terms provided to the Investors in this Agreement. In the event
that EDOC provides the Additional Investors with material terms in the Additional Investor Agreements that are more favorable than the
terms provided to the Investors in this Agreement, EDOC shall promptly inform the Investors of such more favorable terms, and the Investors
shall have the mutual right to elect to have such more favorable terms included herein, in which case the Parties shall promptly amend
this Agreement to effect the same. For the avoidance of doubt, if EDOC transfers or sells Founder Shares to another investor and that
investor also executes a non-redemption agreement or forward share purchase agreement substantially similar to this Agreement, the Investor
shall be notified of such agreement and have the right to amend the terms of this Agreement to match the more favorable terms and/or
the Investor shall have the right elect to have such terms included herein.

 

(h) Security
Agreement in Escrow Account. To secure the obligations of EDOC and the Company under this Agreement, EDOC and the Company each grant
to the Investors a security interest in, and lien on, all right, title, and interest of EDOC and the Company in and to the Escrow Account
in respect of all funds required to satisfy EDOC’s and the Company’s obligations hereunder, the Escrow Agreement, all rights
related thereto, and all proceeds, products, and profits of the foregoing. In the event of a default by EDOC or the Company under this
Agreement or the Escrow Agreement, then, in addition to any other rights the Investors may have under this Agreement, the Escrow Agreement,
and applicable law, the Investors shall also have the rights and remedies of a secured party under the Uniform Commercial Code as enacted
in the State of New York. EDOC and the Company shall use commercially reasonable efforts to prepare and file such UCC financing statements
or other documents as reasonably directed by the Investors with respect to their security interests.

 

    7

     

    

 

(i) Indemnification.
EDOC (referred to as the “Indemnitor”) agrees to indemnify the Investors and their respective officers, directors,
employees, agents and shareholders (collectively referred to as the “Indemnitees”) against, and hold them harmless
of and from, any and all loss, liability, cost, damage and expense, including without limitation, reasonable and documented out-of-pocket
outside counsel fees, which the Indemnitees may suffer or incur by reason of any action, claim or proceeding, in each case, brought by
a third party creditor of EDOC , the Company or any of their respective subsidiaries asserting that the Investors are not entitled to
receive the aggregate Share Purchase Price or such portion thereof as they are entitled to receive pursuant to Section 1(a) and
Section 4(d) of this Agreement, in each case unless such action, claim or proceeding is the result of the fraud, bad faith, willful
misconduct or gross negligence of any Indemnitee.

 

5. Closing
Conditions. The obligation of the Company to purchase the Shares at the Shares Closing under this Agreement shall be subject in all
respects to the consummation of the Business Combination, such Shares being free and clear of all liens and other encumbrances as of
the Shares Closing and such Shares being continuously held by the Investors from the closing of the Business Combination through the
three (3) month anniversary of the Business Combination Closing Date.

 

 6. Termination. This Agreement may be terminated as follows:

 

(a) at
any time by mutual written consent of all Parties;

 

(b) at
the election of the Investors if the stockholders of EDOC fail to approve the Business Combination before August 12, 2022, subject to
extension by mutual agreement; and

 

(c) prior
to the closing of the Business Combination by mutual agreement of the Investors if there occurs a Company Material Adverse Effect (as
defined in the Business Combination Agreement).

 

(d) By
the Investors, if prior to the day that is five (5) business days prior to the date of the Business Combination Meeting, all Parties,
and Continental Stock Transfer & Trust Company, have not executed the Escrow Agreement.

 

(e) By
the Investors, if prior to February 7, 2022, EDOC does not reach substantially similar non-redemption or forward purchase agreements
with Additional Investors committing an aggregate of [2,200,000] Class A ordinary shares of EDOC to the same restrictions included in
Section 4(b) of this Agreement (such shares, in the aggregate, the “Total Backstop Shares”).

 

In
the event of termination in accordance with Section 6(a), 6(b), 6(c), 6(d), or 6(e) this Agreement
shall forthwith become null and void and have no effect, without any liability on the part of [the Investors], EDOC, or the Company and
their respective directors, officers, employees, partners, managers, members, or stockholders and, except as otherwise provided in this
Agreement, all rights and obligations of each Party shall immediately cease; provided, however, that nothing contained in this
Section 6 shall relieve any Party from liabilities or damages arising out of any actual fraud or willful breach by such party
of any of its representations, warranties, covenants or agreements contained in this Agreement prior to termination of this Agreement.

 

    8

     

    

 

 7. General Provisions. 

 

(a) Notices.
All notices and other communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given
upon the earlier of actual receipt, or (i) personal delivery to the Party to be notified, (ii) when sent, if sent by electronic mail
during normal business hours of the recipient, and if not sent during normal business hours, then on the recipient’s next Business
Day, (iii) five (5) Business Days after having been sent by registered or certified mail, return receipt requested, postage prepaid,
or (iv) one (1) Business Day after deposit with a nationally recognized overnight courier, freight prepaid, specifying next Business
Day delivery, with written verification of receipt. All notices and other communications sent to a Party shall be sent to the e-mail
address or address as set forth on the signature page of such Party hereto, or to such e-mail address or address as subsequently modified
by written notice given by such Party in accordance with this Section 7(a).

 

(b) No
Finder’s Fees. Each Party represents that it neither is nor will be obligated for any finder’s fee or commission in connection
with the Transactions. Each Investor agrees to indemnify and to hold harmless EDOC from any liability for any commission or compensation
in the nature of a finder’s or broker’s fee arising out of the Transactions (and the costs and expenses of defending against
such liability or asserted liability) for which the Investors, or any of their respective officers, employees or representatives is responsible
or arising out of any agreement entered into by any such person or entity. EDOC agrees to indemnify and hold harmless the Investors from
any liability for any commission or compensation in the nature of a finder’s or broker’s fee arising out of the Transactions
(and the costs and expenses of defending against such liability or asserted liability) for which EDOC or any of its officers, employees
or representatives is responsible or arising out of any agreement entered into by any such person or entity.

 

(c) Survival
of Representations and Warranties. All of the representations and warranties contained herein shall survive the Shares Closing.

 

(d) Entire
Agreement. This Agreement, together with any documents, instruments and writings that are delivered pursuant hereto or referenced
herein, constitute the entire agreement and understanding of the Parties in respect of its subject matter and supersedes all prior understandings,
agreements, or representations by or among the Parties, written or oral, to the extent they relate in any way to the subject matter hereof
or to the Transactions.

 

(e) Successors.
All of the terms, agreements, covenants, representations, warranties, and conditions of this Agreement are binding upon, and inure to
the benefit of and are enforceable by, the Parties and their respective successors. Nothing in this Agreement, express or implied, is
intended to confer upon any party other than the Parties or their respective successors and assigns any rights, remedies, obligations
or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement.

 

(f) Assignments.
Except as otherwise specifically provided herein, no Party may assign either this Agreement or any of its rights, interests, or obligations
hereunder without the prior written approval of the each of the other Parties.

 

(g) Counterparts.
This Agreement may be executed in two or more counterparts, each of which will be deemed an original but all of which together will constitute
one and the same instrument. Signatures sent by facsimile transmission or in PDF format shall be deemed to be originals for all purposes
of this Agreement.

 

(h) Headings.
The section headings contained in this Agreement are inserted for convenience only and will not affect in any way the meaning or interpretation
of this Agreement.

 

    9

     

    

 

(i) Governing
Law; Jurisdiction. This Agreement, the entire relationship of the Parties, and any litigation among the Parties (whether grounded
in contract, tort, statute, law or equity) shall be governed by, construed in accordance with, and interpreted pursuant to the laws of
the State of Delaware, without giving effect to its choice of laws or conflict of law provision or rule (whether of the State of Delaware
or any other jurisdiction) that would cause the application of the laws of any jurisdiction other than the State of Delaware. Any dispute
arising from or relating to the relative rights of the parties hereto and all other questions concerning the construction, validity and
interpretation of this Agreement, shall be brought exclusively in the Court of Chancery of the State of Delaware (the “Court
of Chancery”) or, to the extent the Court of Chancery does not have subject matter jurisdiction, the United States District
Court for the District of Delaware and the appellate courts having jurisdiction of appeals in such courts (the “Delaware Federal
Court”) or, to the extent neither the Court of Chancery nor the Delaware Federal Court has subject matter jurisdiction, the
Superior Court of the State of Delaware (the “Chosen Courts”), and, solely with respect to any such action (i) irrevocably
submits to the exclusive jurisdiction of the Chosen Courts, (ii) waives any objection to laying venue in any such action in the
Chosen Courts, and (iii) waives any objection that the Chosen Courts are an inconvenient forum or do not have jurisdiction over any party
hereto.

 

(j) MUTUAL
WAIVER OF JURY TRIAL. EACH PARTY TO THIS AGREEMENT HEREBY WAIVES ALL RIGHTS TO TRIAL BY JURY IN ANY ACTION, SUIT, OR PROCEEDING BROUGHT
TO RESOLVE ANY DISPUTE BETWEEN OR AMONG ANY OF THE PARTIES HERETO, WHETHER ARISING IN CONTRACT, TORT, OR OTHERWISE, ARISING OUT OF, CONNECTED
WITH, RELATED OR INCIDENTAL TO THIS AGREEMENT AND/OR THE TRANSACTIONS CONTEMPLATED HEREBY.

 

(k) Amendments.
This Agreement may not be amended, modified or waived as to any particular provision, except with the prior written consent of all Parties.

 

(l) Severability.
The provisions of this Agreement will be deemed severable and the invalidity or unenforceability of any provision will not affect the
validity or enforceability of the other provisions hereof; provided that if any provision of this Agreement, as applied to any
Party or to any circumstance, is adjudged by a governmental authority, arbitrator, or mediator not to be enforceable in accordance with
its terms, the Parties agree that the governmental authority, arbitrator, or mediator making such determination will have the power to
modify the provision in a manner consistent with its objectives such that it is enforceable, and/or to delete specific words or phrases,
and in its reduced form, such provision will then be enforceable and will be enforced.

 

(m) Expenses.
At the Business Combination Closing Date, EDOC shall pay the reasonable and documented out-of-pocket fees and expenses of legal counsel
to the Investors, in an amount not to exceed, in the aggregate $10,000. EDOC and the Company are responsible for all fees associated
with the Escrow Account.

 

(n) Exclusivity.
EDOC represents that it has not entered into any similar agreements with any other parties prior to the execution of this Agreement.
EDOC may enter into a similar non-redemption or forward purchase agreement with [up to four] other parties, for a maximum aggregate [2,200,000]
shares, subject to the terms of Section 4(g).

 

    10

     

    

 

(o) Construction.
The Parties have participated jointly in the negotiation and drafting of this Agreement. If an ambiguity or question of intent or interpretation
arises, this Agreement will be construed as if drafted jointly by the Parties and no presumption or burden of proof will arise favoring
or disfavoring any Party because of the authorship of any provision of this Agreement. For purposes of this Agreement, “Business
Day” means any day other than Saturday, Sunday, or a day on which commercial banks in New York are obligated by any applicable
law to close. Any reference to any federal, state, local, or foreign law will be deemed also to refer to law as amended and all rules
and regulations promulgated thereunder, unless the context requires otherwise. The words “include,” “includes,”
and “including” will be deemed to be followed by “without limitation.” Pronouns in masculine, feminine,
and neuter genders will be construed to include any other gender, and words in the singular form will be construed to include the plural
and vice versa, unless the context otherwise requires. The words “this Agreement,” “herein,” “hereof,”
“hereby,” “hereunder,” and words of similar import refer to this Agreement as a whole and not to
any particular subdivision unless expressly so limited. The Parties intend that each representation, warranty, and covenant contained
herein will have independent significance. If a Party has breached any representation, warranty, or covenant contained herein in any
respect, the fact that there exists another representation, warranty or covenant relating to the same subject matter (regardless of the
relative levels of specificity) which such party has not breached will not detract from or mitigate the fact that such party is in breach
of the first representation, warranty, or covenant.

 

(p) Waiver.
No waiver by a Party of any default, misrepresentation, or breach of warranty or covenant hereunder, whether intentional or not, may
be deemed to extend to any prior or subsequent default, misrepresentation, or breach of warranty or covenant hereunder or affect in any
way any rights arising because of any prior or subsequent occurrence.

 

(q) Specific
Performance. Each Party agrees that irreparable damage may occur in the event any provision of this Agreement was not performed by
any other Party in accordance with the terms hereof and that the other Parties shall be entitled to seek specific performance of the
terms hereof, in addition to any other remedy at law or equity.

 

(r) Rule 10b5-1.

 

		i.	Edoc
                                            represents and warrants to the Investors that Edoc is not entering into this Agreement to
                                            create actual or apparent trading activity in the Shares (or any security convertible into
                                            or exchangeable for the Shares) or to raise or depress or otherwise manipulate the price
                                            of the Shares (or any security convertible into or exchangeable for the Shares) for the purpose
                                            of inducing the purchase or sale of such securities or otherwise in violation of the Exchange
                                            Act, and Edoc represents and warrants to the Investors that Edoc has not entered into or
                                            altered, and agrees that Edoc will not enter into or alter, any corresponding or hedging
                                            transaction or position with respect to the Shares.
	 	 	 

		i.	Edoc
                                            agrees that, subject to Section 4(a) herein, it will not seek to control or influence the
                                            Investors’ decision to make any “purchases or sales” (within the meaning
                                            of Rule 10b5-1(c)(1)(i)(B)(3)) under this Agreement, including, without limitation,
                                            the Investors’ decision to enter into any hedging transactions.
	 	 	 

		ii.	Edoc
                                            acknowledges and agrees that any amendment, modification, waiver or termination of this Agreement
                                            shall be made in good faith and not as part of a plan or scheme to evade the prohibitions
                                            of Rule 10b-5.

 

[Signature
page follows]

 

    11

     

    

 

IN
WITNESS WHEREOF, the undersigned have executed this Agreement to be effective as of the date first set forth above.

 

	[INVESTOR]:	 
	[__]	 	 
	 	 	 
	By: 	                           	 
	Name: 	 	 
	Title: 	 	 
	 	 	 
	Address for Notices:	 
	[address]	 
	[email]	 
	 	 	 
	[INVESTOR]:	 
	[__]	 	 
	 	 	 
	By:  	 	 
	Name: 	 	 
	Title:  	 	 
	 	 	 
	Address for Notices:	 
	[address]	 
	[email]	 	 
	 	 	 
	EDOC:	 
	Edoc Acquisition Corp.	 
	 	 	 
	By: 	      	 
	Name: 	 	 
	Title:  	 	 
	 	 	 
	Address for Notices:	 
	[address]	 
	[email]	 	 

 

    12

     

    

 

Appendix
A

 

	Investor	 	Number
    of Shares
	 	 	 
	 	 	 
	 	 	 
	 	 	 

 

    13

     

    

 

Exhibit
A

 

Escrow
Agreement

 

(attached
hereto)

 

 

14Exhibit 10.8

 

SHARE TRANSFER AGREEMENT

 

This Share Transfer Agreement
(“Agreement”), dated February [__], 2022, among [Investor Name], (each of [__] and [__] an “Investor”,
and collectively the “Investors”) and American Physicians LLC (the “Sponsor”).

 

RECITALS:

 

A.  EDOC
Acquisition Corp., a Cayman Islands exempted company (the “EDOC” or “SPAC”) will hold a special
meeting of its shareholders (“Business Combination Meeting”) to consider and act upon, among other things, a proposal
(the “Acquisition Proposal”) to adopt and approve certain proposed transactions pursuant to that certain EDOC has entered
into an Business Combination Agreement and Plan of Merger, dated as of February [__], 2022 (the “Business Combination Agreement”),
by and among EDOC and Calidi Biotherapeutics, Inc., a Nevada corporation ( “Calidi”) among others, which agreement provides
for, among other things, the acquisition of Calidi by EDOC (such transactions, the “Business Combination”).

 

B. In
the event that the SPAC believes it will not be able to consummate the Business Combination on or prior to February 12, 2022, SPAC intends
to hold a special meeting of shareholders (the “Extension Meeting”) to approve, among other things, a proposal (the
“Extension Proposal”) to amend SPAC’s amended and restated memorandum and articles of association to extend the
date by which EDOC has to consummate a business combination (the “Extension”) from February 12, 2022 to August 12,
2022.

 

C. The Investors have agreed
not to seek redemption of up to [__] class A ordinary shares (the “Subject Shares”) issued in SPAC’s initial public
offering (“Public Shares”) upon the terms set forth herein.

 

IT IS AGREED:

 

 1. Non-Redemption and Voting.

 

 (a) The Investors hereby agree not to request redemption of any Subject Shares at the Extension Meeting and vote in favor of the Extension Proposal; provided, however, that the Investors shall not be prohibited from seeking redemption with respect to any other Public Shares held by the Investors at the Extension Meeting.

 

 (b) Further, the Investors agree not to seek redemption of any Subject Shares at the Meeting to approve the Acquisition Proposal, subject to the terms of the executed Forward Purchase Agreement, and vote in favor of the Acquisition Proposal; provided, however, that the Investors shall not be prohibited from seeking redemption with respect to any other Public Shares held by the Investors at a Meeting to approve the Acquisition Proposal.

 

 2. Net Long. During the term of this Agreement, Investor agrees to maintain a net long position of the SPAC’s securities and to acquire Subject Shares in connection with each of the Extension Meeting and Business Combination Meeting as set forth in that certain Forward Purchase Agreement between the parties, dated as of the date hereof.

 

 3. Insider Stock Transfers. In consideration of the agreements set forth in Section 1 hereof:

 

 (a) the Sponsor (or its designees) will transfer, within five (5) Business Days following the date of the Extension Meeting (the “Extension Meeting Date”), to the Investors, an aggregate of [__] of SPAC’s Class B ordinary shares (“Founder Shares”) beneficially owned by it (or its designees).

 

     

     

    

 

 (b) If the Business Combination has not consummated by May 12, 2022, then for each monthly period from May 12, 2022 until August 12, 2022 that the Business Combination has not closed (each such monthly period, a “Month”), then SPAC shall cause to be paid to the Investor, at SPAC’s discretion, either (i) a cash amount of $0.05 per Subject Share not redeemed by the Investors, for an aggregate of up to $0.15 per Public Share, or (ii) or 0.034 Founder Shares per Subject Share not redeemed by the Investors to be transferred by the Sponsor (or its designees), for an aggregate of up to 0.1027 Founder Shares per share. Such payment(s) shall be made within five (5) business days following each of May 12, 2022, June 12, 2022, and July 12, 2022, to the extent that the Business Combination has not closed by such dates. The Sponsor hereby agrees to transfer Founder Shares to the Investors in accordance with this Section 3(B) if the SPAC elects for one or more of such payments to be made to the Investors to be made pursuant to clause (ii) hereof.

 

 (c) Notwithstanding anything to the contrary herein, the number of Founder Shares transferred to the Investors shall not be subject to lock-up (except as set forth In the Insider Letter (defined below), earn-out, cut-back, reduction, mandatory repurchase, redemption or forfeiture for any reason, including (i) transfer of the Founder Shares to any person, (ii) concessions or “earn-out” triggers in connection with the negotiation of a Business Combination Agreement, (iii) or any other modification, without the Investor’s prior written consent. The Founder Shares shall be re-issued in the name of the Investors either in physical certificate form or electronically using Depository Trust Company’s DWAC (Deposit Withdrawal at Custodian) System, as directed by the Investors. The Sponsor hereby assigns to the Investors (x) its registration rights pursuant to that certain Registration Rights Agreement, dated as of November 9, 2020, with respect to the Founder Shares being transferred to the Investors hereunder, and (y) its rights and obligations pursuant to that certain Letter Agreement, dated as of November 9, 2020, with respect to certain restrictions and voting obligations relating to the Founder Shares being transferred to the Investors hereof (the “Insider Letter”). The Company consents to such assignment of registration rights to the Investors by the Sponsor and agrees that no provision of the Registration Rights Agreement or Insider Letter shall be amended in a manner adverse to the Investors without the written consent of the Investors. Each Investor will be subject to the terms of the Insider Letter (and related definitional, enforcement and general provisions), as if it were an original undersigned party thereto; provided; however, that if any provision of the Insider Letter is amended in a manner more favorable to the Investor (e.g., a shorter lock-up period), the Insider Letter shall be deemed amended with respect to the Investors but only to provide for such more favorable terms.

 

4.  Representations
of the Investors. Each Investor hereby represents and warrants to the Sponsor that:

 

(a) The Investor,
in making the decision to receive the Founder Shares from the Sponsor, have not relied upon any oral or written representations or assurances
from the Sponsor or any of SPAC’s officers, directors, partners or employees or any other representatives or agents, except as set
forth in this Agreement.

 

(b) This
Agreement has been validly authorized, duly executed and delivered by such Investor and, assuming the due authorization, execution and
delivery thereof by the other party hereto, is a valid and binding agreement enforceable in accordance with its terms, subject to the
general principles of equity and to bankruptcy or other laws affecting the enforcement of creditors’ rights generally. The execution,
delivery and performance of this Agreement by the Investors do not and will not conflict with, violate or cause a breach of, constitute
a default under, or result in a violation of (i) any agreement, contract or instrument to which the Investors are a party which would
prevent such Investor from performing its obligations hereunder or (ii) any law, statute, rule or regulation to which such Investor is
subject.

 

    2

     

    

 

(c) The Investor
acknowledges that it has had the opportunity to review this Agreement and the transactions contemplated by this Agreement with the
Investor’s own legal counsel and investment and tax advisors.

 

(d) Investor is duly organized,
validly existing and in good standing under the laws of the jurisdiction in which it was formed.

 

(e) The Investor is record
and beneficial owner (within the meaning of Rule 13d-3 under the Exchange Act) of, and have good title to, all of the Subject Shares,
and there exist no liens or any other limitation or restriction (including any restriction on the right to vote, sell or otherwise dispose
of such securities (other than transfer restrictions under the Securities Act)) affecting any such securities.

 

(f) There are no actions
pending against the Investor or, to the Investor’s knowledge, threatened against the Investor, before (or, in the case of threatened
actions, that would be before) any arbitrator or any governmental authority, which in any manner challenges or seeks to prevent, enjoin
or materially delay the performance by the Investor of its obligations under this Agreement.

 

5.  Sponsor
Representations. The Sponsor hereby represents and warrants to the Investors that:

 

(a) This Agreement
has been validly authorized, executed and delivered by it and, assuming the due authorization, execution and delivery thereof by the other
party hereto, is a valid and binding agreement enforceable in accordance with its terms, subject to the general principles of equity and
to bankruptcy or other laws affecting the enforcement of creditors’ rights generally. The execution, delivery and performance of
this Agreement by the Sponsor does not and will not conflict with, violate or cause a breach of, constitute a default under, or result
in a violation of (i) any agreement, contract or instrument to which the Sponsor is a party which would prevent the Sponsor from performing
its obligations hereunder or (ii) any law, statute, rule or regulation to which the Sponsor is subject.

 

(b) The
Sponsor (or its designees) is the record and beneficial owner of the Founder Shares and will transfer them to the Investors immediately
prior to the applicable Share Transfer Date free and clear of any liens, claims, security interests, options charges or any other encumbrance
whatsoever, except for restrictions imposed by federal and state securities laws and the terms set forth in the Insider Letter.

 

 (c) Neither the Sponsor not the Company have disclosed to the Investors material non-public information with respect to the Company or the Business Combination, other than any such information that shall be publicly disclosed by the Sponsor either by the issuance of a press release or the filing with the U.S. Securities and Exchange Commission a Current Report on Form 8-K, in each case, by 9:30 a.m., Eastern Time on the first Business Day immediately following the date that the Sponsor and Investors enter into this Agreement. Such public disclosure shall disclose the name of the Investors as having entered into the Agreement.

 

 (d) Compliance with Other Instruments. The execution, delivery and performance by the Sponsor of this Agreement and the consummation by the Sponsor of this Agreement will not result in any violation or default (i) of any provisions of its organizational documents, (ii) of any instrument, judgment, order, writ or decree to which it is a party or by which it is bound, (iii) under any note, indenture or mortgage to which it is a party or by which it is bound, (iv) under any lease, agreement, contract or purchase order to which it is a party or by which it is bound, or (v) of any provision of federal or state statute, rule or regulation applicable to it, in each case (other than clause (i)), which would have a material adverse effect on the Sponsor or its ability to consummate the Business Combination.

 

    3

     

    

 

 (e) There are no actions pending against the Sponsor or the Company, to the Sponsor’s or the Company’s knowledge, threatened against the Sponsor or the Company, before (or, in the case of threatened actions, that would be before) any arbitrator or any governmental authority, which in any manner challenges or seeks to prevent, enjoin or materially delay the performance by the Investors of their obligations under this Agreement.

 

6.  Disclosure;
Exchange Act Filings. Promptly after execution of this Agreement, the Company will file a Current Report on Form 8-K under the Securities
Exchange Act of 1934, as amended (the “Exchange Act”) reporting the execution of this Agreement. The parties to this
Agreement shall cooperate with one another to assure that such disclosure is accurate.

 

7.  Entire
Agreement; Amendment. This Agreement constitutes the entire agreement among the parties with respect to the subject matter hereof
and may be amended or modified only by written instrument signed by all parties. The headings in this Agreement are for convenience of
reference only and shall not alter or otherwise affect the meaning hereof.

 

8.  Governing
Law. This Agreement shall be governed by and construed in accordance with the law of the State of New York, including the conflicts
of law provisions and interpretations thereof. 

 

9.  Counterparts.
This Agreement may be executed in one or more counterparts, and by the different parties hereto in separate counterparts, each of which
when executed shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. Delivery
of an executed signature page by facsimile or other electronic transmission shall be effective as delivery of a manually signed counterpart
of this Agreement.

 

10.  Termination.
Notwithstanding any provision in this Agreement to the contrary, this Agreement shall become null and void and of no force and effect,
and all parties shall be released from all obligations under this Agreement: (i) if the Business Combination is not consummated by August
12, 2022 or (iii) if SPAC does not reach substantially similar non-redemption or forward purchase agreements with other investors committing
an aggregate of [2,200,000] Class A ordinary shares and notifies the Investors that such agreements have been executed on or prior to
February 7, 2022. For the avoidance of doubt, if the Business Combination is not consummated by August 12, 2022 the Investors shall not
be required to forfeit or transfer any Founder Shares already transferred to it pursuant to Section 3 herein.

 

11.  Remedies.
Each of the parties hereto acknowledges and agrees that, in the event of any breach of any covenant or agreement contained in this Agreement
by the other party, money damages may be inadequate with respect to any such breach and the non-breaching party may have no adequate remedy
at law. It is accordingly agreed that each of the parties hereto shall be entitled, in addition to any other remedy to which they may
be entitled at law or in equity, to seek injunctive relief and/or to compel specific performance to prevent breaches by the other party
hereto of any covenant or agreement of such other party contained in this Agreement.

 

12.  Binding
Effect; Assignment. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective legal
representatives, successors and permitted assigns. This Agreement shall not be assigned by either party without the prior written consent
of the other party hereto.

 

    4

     

    

 

13. Most Favored Nation.
In the event the Sponsor enters into separate agreements with other investors in respect of the purchase of ordinary shares, before or
after the execution of this Agreement, and subsequent non-redemption agreement, the Sponsor represents that the material terms of such
other agreements are or will be no more favorable to such other investors thereunder than the terms of this Agreement are in respect of
the Investors. In the event that another investor is afforded any such more favorable terms than the Investors, the Sponsor shall promptly
so inform the Investors of such more favorable terms, and the Investors shall have the right to elect to have such more favorable terms
included herein, in which case the parties hereto shall promptly amend this Agreement to effect the same. For the avoidance of doubt,
if the Sponsor transfers or sells Founder Shares to another investor and that investor also executes a non- redemption agreement or forward
share purchase agreement substantially similar to this Agreement, the Investors shall be notified of such agreement and have the right
to amend the terms of this Agreement to match the more favorable terms and/or the Investors shall have the right elect to have such terms
included herein

 

14. Indemnification.
The Sponsor and the Company (referred to as the “Indemnitors”) shall both agree to indemnify the Investors and their
respective officers, directors, employees, agents and shareholders (collectively referred to as the “Indemnitees”)
against, and hold them harmless of and from, any and all loss, liability, cost, damage and expense, including without limitation, reasonable
and documented out-of-pocket outside counsel fees, incurred as a result of any claim, suit or proceeding, whether civil, criminal, administrative
or arbitrative brought against the Sponsor or Company that makes any Investor a party, or brought against the Investors in relation to
this Agreement.

 

16. Notification.
The Sponsor and/or Company shall promptly notify the Investors of the occurrence of any event that would make any of the representations
and warranties of the Sponsor and/or Company untrue or incorrect at any time between the date of this Agreement and the consummation of
the Business Combination.

 

17. SEC Filings. None
of the Company’s reports and other filings with the U.S. Securities and Exchange Commission, as of their respective dates, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary to make the statements
therein, in light of the circumstances under which they were made, not misleading.

 

17. Trust
Fund Waiver. Each Investor acknowledges that EDOC has established a trust account (“Trust Account”) for the benefit
of EDOC’s public stockholders and that disbursements from the Trust Account are available only in the limited circumstances as described
in the SEC Reports. Each Investor further acknowledges and agrees that EDOC’s sole assets consist of the cash proceeds of EDOC’s
initial public offering and private placements of its securities, and that substantially all of these proceeds have been deposited in
the Trust Account for the benefit of its public stockholders. Each Investor (on behalf of itself and its affiliates) hereby waives any
past, present or future claim of any kind against, and any right to access, the Trust Account and any funds contained therein for any
reason whatsoever, and will not seek recourse against the Trust Account at any time for any reason whatsoever; provided, however, that
nothing herein shall serve to limit or prohibit the Investors’ right to pursue a claim against the Company for (i) legal relief
against monies or other assets held outside the Trust Account or assets released from the Trust Account and remaining after distribution
to public shareholders following the consummation of a business combination or (ii) specific performance or other equitable relief in
connection with the consummation of the transactions contemplated by this Agreement so long as such claim would not affect EDOC’s
ability to fulfill its obligation to effectuate redemption of public shares as described in the SEC Reports. Notwithstanding
the foregoing, nothing in this Section 17 shall be deemed to limit any Investor’s right, title, interest or claim to any monies
in connection with distributions from the Trust Account with respect to any Public Shares then held by such Investor pursuant to any liquidation
rights relating to the Public Shares in the event that SPAC ceases all operations and dissolves the Company prior to closing a Business
Combination.

 

18. Inconsistent Agreements.
Investors hereby covenant and agree that, except for this Agreement and any other forward share purchase agreement that the Investor may
enter into with the SPAC, each (a) shall not enter into at any time while this Agreement remains in effect, any voting agreement or voting
trust with respect to the Subject Shares and (b) shall not grant at any time while this Agreement remains in effect a proxy, consent or
power of attorney with respect to the Subject Shares.

 

    5

     

    

 

19. Covenants of Investors.
Each Investor hereby: (a) agrees to promptly notify the Company and SPAC to comply with relevant SEC disclosure requirements or to confirm
the fulfillment of the Investor’s obligations pursuant to Section 2 herein, upon the reasonable request of the Company or SPAC,
of the number of any new securities acquired by such Investor after the date hereof until the closing of the Business Combination (any
such new securities being subject to the terms of this Agreement as “Public Shares” but not Subject Shares, as though owned
by the Investor on the date hereof); provided that any such requests shall only be made from time to time as may be reasonably needed
to effect the Extension or the Business Combination, as the case may be; (b) agrees to permit SPAC and the Company to publish and disclose
Investor's identity, ownership of the Public Shares and the nature of Investor's commitments, arrangements and understandings under this
Agreement, and, if deemed appropriate by SPAC or the Company, a copy of this Agreement, in (i) the Registration Statement/Proxy Statement,
(ii) any Form 8-K or 6-K filed by the Company or SPAC with the SEC in connection with the execution and delivery of the Business Combination
Agreement and the Registration Statement/Proxy Statement, and (iii) any other documents or communications provided by SPAC or the Company
to any governmental authority or to security holders of SPAC, in each case, to the extent required by the federal securities laws or the
SEC or any other securities authorities.

 

[Signature Page Follows]

 

    6

     

    

 

IN WITNESS WHEREOF, the parties have executed
this Agreement as of the date first above written.

 

	 	SPONSOR:
	 	 
	 	By: 	           
	 	Name: 	  
	 	Title:	 

 

	 	COMPANY:
	 	 
	 	By: 	                      
	 	Name: 	 
	 	Title:	 
	 	 	 

 

	 	[INVESTOR NAME]:
	 	 
	 	
    By: 
	                     
	 	Name: 	 
	 	Title:	 

 

	 	[INVESTOR NAME]:
	 	 
	 	By: 	                      
	 	Name: 	 
	 	Title:	 

 

[Signature Page to the Share Transfer Agreement]

 

 

7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00339-of-00352.parquet"}]]